ABSTRACT OBJECTIVES This study aimed to create decision aids (DAs) for patients considering a destination therapy left ventricular assist device (DT LVAD).
However, significant risks accompany a DT LVAD, including stroke, serious infection, severe bleeding, and reoperation; chronic conditions that make patients ineligible for a transplant persist; and significant lifestyle changes occur, including the need for patients to be connected to electricity at all times (1, 2) . Furthermore, many implanting programs require formal commitment from a proposed caregiver as part of eligibility, which places substantial responsibility on a family member or friend (3) .
Given these complex trade-offs, shared decision making, guided by standardized methods and materials to support the decision process, has been encouraged by several organizations (4) and is supported by a large body of literature (5, 6) . Unfortunately, patients, caregivers, and clinicians have had suboptimal guidance and support for DT LVAD decision making: existing informed consents are written at a high reading comprehension level, whereas industry materials are optimistically biased, contain outdated statistics, and fail to adequately discuss risks (7) . These industry materials are widely used among LVAD centers (8) . Although the ethical mandate surrounding informed consent is clear (9) , achieving true informed consent in this setting is challenging when consent forms and industry materials alone are used (4) .
Decision aids (DAs) have emerged as an effective intervention to improve patients' decision making (5) . The International Patient Decision Aid Standards (IPDAS) collaboration has released several guidelines and standards on both how to develop DAs and how to ensure they are of quality (10, 11) . Many DAs have been developed and studied in randomized trials; however, only a small minority are related to decisions faced by people with advanced illness, and end-of-life decisions were specifically excluded from the Cochrane review of DAs (6) . Currently, no widely available DT LVAD informational materials meet criteria for a patient DA (7) , and no standard education and consent processes exist across different hospitals and LVAD programs (8) .
We aimed to develop novel DAs for patients offered DT LVAD. To first understand stakeholders' decisional needs, a needs assessment was performed with patients, caregivers, and mechanical circulatory support (MCS) coordinators (8, 12, 13) , which revealed several important findings: 1) the decision-making process is highly emotional and often dominated by fear of death; 2) these emotions and the high-stakes nature of the clinical circumstances create a situation in which many patients do not cognitively engage declination of DT LVAD as an option, instead focusing on doing "anything it takes"; 3) caregivers are deeply involved in the decision-making process and subsequent care of the patient and often feel a tension between gratitude and burden; 4) caregivers often project personal desires onto patients' decision making, with many feeling a tension between wanting to be involved while also wanting to support the patients' decisions; 5) MCS coordinators desire an iterative, multidisciplinary approach to DT LVAD education; and 6) coordinators feel a tension between wanting to explain all aspects of DT LVAD to patients and not wanting to overwhelm or "scare" them away from the device.
Guided by IPDAS and the needs assessment, and also attending to the unique nature of the DT LVAD decision process, we developed 2 novel DT LVAD DAs for patients and their caregivers. Herein, we describe the methods of development and provide illustrative examples of important aspects of our DAs.
METHODS
DEVELOPMENT TEAM. The core development team consisted of an advanced heart failure cardiologist, a geriatric and palliative medicine physician, a nurse practitioner specializing in the care of patients with LVADs, and a health communication specialist. All aspects of the study received approval from the Colorado Multiple Institutional Review Board, and written or verbal informed consent was obtained from patient and caregiver participants.
FRAMEWORK. DA development was guided by: 1) the Ottawa Decision Support Framework (14) , which dictated we complete preliminary assessments to understand stakeholders' decisional needs as a foundation for DA development; and 2) IPDAS, which provided a model for systematic DA development and evidence-based criteria to ensure our DAs were of quality (10,11). Additionally, we further 
explored domains identified as important during the framework-guided needs assessment, as detailed in the Introduction (8, 12, 13) . we completed an environmental scan to ensure the need for a DT LVAD DA existed (7), conducted a systematic review of the literature to ensure all data in the DAs were accurate and current (1) , and completed the needs assessment of relevant stakeholders.
Because patients considering DT LVAD are often very ill, we chose 2 DA formats easily implementable into Summary of the methods and main results of the paper. LVAD ¼ left ventricular assist device.
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specialists in cardiology, advanced heart failure, and palliative care to ensure the DAs would be acceptable in real-world practice. Additional nationwide feedback was solicited in person, over the telephone,
and through e-mail from MCS coordinators, cardiologists, palliative care specialists, nurses, and social psychologists.
RESULTS
A total of 24 patients and 20 caregivers were interviewed. All but 4 patient and caregiver interviews were conducted in person, lasting a median of 37 min.
Clinician feedback came from local cardiology and palliative care groups, as well as 24 external clinicians from 16 medical centers across the United
States. Demographic information for participants is provided in Table 1 . In addition to following IPDAS criteria (see "Final Versions" below for details), we took a deeper and nuanced approach to certain developmental aspects deemed particularly important to this clinical situation, as detailed below and in Table 2 . 
Caregiver relationship to patient
Values are number of respondents unless otherwise specified.
BTT it helpful to discuss death, and retrospectively, many prefer direct and honest communication (22, 23) .
TONE AND BALANCE. Because of mixed responses related to tone (patients and caregivers saw the paper DA as too negative, whereas clinicians worried the DA was overly in favor of the LVAD), careful changes were made to the language of the DAs to address the concern about negativity, while also keeping the DAs an honest depiction of the decision. A focus Fear of death "Whether we like it or not, everybody eventually dies." "We don't want to die, you know, the first reaction is, I'll do whatever it takes to live, and then coming to grips with the fact that we all die at some point."
Patient, caregiver, and clinician needs assessments; alpha testing
Many participants expressed that direct language in the DAs served as an important reminder for patients and caregivers going through the decision. Several caregivers commented on how crucial this acknowledgment is during decision making.
Tone and balance "Think about how you hope to live the rest of your life." "You have some control over how you will live the rest of your life." "The right choice really depends on how you hope to live the rest of your life." "Life with an LVAD" and "Life without an LVAD" Alpha testing Initially, several patients and caregivers thought the DA was too negative toward the LVAD and made it seem "overwhelming" or "burdensome," but many of these same participants also appreciated the realistic, "blunt" depiction. Some clinicians acknowledged how language about death and complications was necessary to convey the seriousness of the choice, whereas the majority of cardiologists considered initial versions of the DA to be overly in favor of LVAD, failing to convey the gravity of the decision. 
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on "living" with or without an LVAD was inserted.
The language was adjusted until participant comments on bias were equally balanced. Following the tenets of fuzzy-trace theory, we iteratively refined our presentation to merge emotive and Nearly all of the participants stated they liked the values clarification exercises, and many took time to complete the written activities on the paper DA. The response to the testimonials was overwhelmingly positive among all participant groups. Participants reported the testimonials presented a variety of experiences with the decision-making process and life with or without an LVAD, and they appreciated the balanced presentation of outcomes.
In the first version of the DA, the wife of a decliner was included; however, many participants reported a desire to see the decliner patient perspective directly. For version 2 of the video, we were able to include a patient who declined DT LVAD. Thompson et al.
FIGURE 3 Paper Decision Aid Excerpt
Page showing options, presenting probabilities, using statistics, and highlighting uncertainty. Because the majority of people without a left ventricular assist device (LVAD) die imminently, this option required unique framing regarding benefits, risks, and burdens.
clarification exercises, including a quantity versus quality of life scale and a pros and cons list for each option. Both DAs used implicit values clarification through language at the beginning and end asking patients to consider their values, goals, and imagined futures (25) . The DAs also contained a balanced presentation of patient and caregiver experiences. These testimonials helped provide a voice to values, decision-making processes, and realworld experiences. However, the evidence behind the use of patient testimonials is conflicting. Although testimonials can be beneficial in helping people understand, remember, and relate to information, they can also be biasing; concerns have been raised about the biased use of relatively healthy LVAD recipients in routine education (8, (26) (27) (28) . We made a conscious effort to include a wide range of experiences that were balanced and showed a range of perspectives.
In addition, we focused on testimonials that were primarily process and experience focused, as recommended by IPDAS and others (10, 28) . Quotations were used in the paper DA, and interview clips were used in the video. 
